Research Center for Infectious Diseases

Menu
ThayVinh

Nguyen Phuoc Vinh, PhD

Collaborating PI

Research Interest(s)

  • Pharmacology
  • Pharmaceutical industry
  • Application of nanotechnology in the development of new drug forms

Education

  • BS., Ho Chi Minh City Medicine and Pharmacy University, Vietnam
  • MS., Paris-Saclay University, Paris, France
  • Ph.D., Tours University, Tours, France

Publications

  1. Phuoc Vinh Nguyen, Katel Hervé-Aubert, Laurie Lajoie, Yoann Misericordia, Igor Chourpa, Stéphanie David, Emilie Allard-Vannier; In vitro synergistic activity of cisplatin and EGFR-targeted nanomedicine of anti-Bcl-xL siRNA in a non-small lung cancer cell line model, International Journal of Pharmaceutics: X (2022), Volume 4,2022,https://doi.org/10.1016/j.ijpx.2022.100139.
  2. Nguyen, P.-V.; Allard-Vannier, E.; Aubrey, N.; Labrugère-Sarroste, C.; Chourpa, I.; Sobilo, J.; Le Pape, A.; Hervé-Aubert, K. Radiolabeling, Quality Control and In Vivo Imaging of Multimodal Targeted Nanomedicines. Pharmaceutics 2022, 14, 2679. https://doi.org/10.3390/pharmaceutics14122679
  3. Nguyen, P.V.; Aubry, C.; Boudaoud, N.; Gaubert, A.; Langlois, M.-H.; Marchivie, M.; Gaudin, K.; Arpin, C.; Barthélémy, P.; Kauss, T. Oligonucleotide Solid Nucleolipid Nanoparticles against Antibiotic Resistance of ESBL-Producing Bacteria. Pharmaceutics (2022), 14, 299.
  4. Nguyen PV, Hervé-Aubert K, Chourpa I, Allard-Vannier E. Active targeting strategy in nanomedicines using anti-EGFR ligands – A promising approach for cancer therapy and diagnosis. Int J Pharm. 2021 Nov 20;609:121134.
  5. Nguyen PV, Allard-Vannier E, Chourpa I, Hervé-Aubert K. Nanomedicines functionalized with anti-EGFR ligands for active targeting in cancer therapy: Biological strategy, design and quality control. Int J Pharm. 2021 Aug 10; 605:120795
  6. Nguyen PV, Hervé-Aubert K, David S, Lautram N, Passirani C, Chourpa I, Aubrey N, Allard-Vannier E. Targeted nanomedicine with anti-EGFR scFv for siRNA delivery into triple negative breast cancer cells. Eur J Pharm Biopharm. 2020 Dec;157:74-84.
  7. Kauss T., Corinne A., Léa B., Nguyen P.V., Brune V., Sebastien B., and Philippe B. Lipid Oligonucleotides as a New Strategy for Tackling the Antibiotic Resistance. Scientific Reports, 2020, 10 (1): 1054.

Awards

2022: Excellent Award of  Pharmaceutics, Prize of the French Academy of Pharmacology 

2022: First prize in the 21st Youth Science and Technology Conference in the Health Industry, given by Vietnam’s Ministry of Health and the Central Executive Board of Ho Chi Minh Communist Youth Union